Clinical trial
Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC
NCT06864819 is registered in ClinicalTrials.gov with University Hospitals Cleveland Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC
- Lead sponsor
- University Hospitals Cleveland Medical Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 5, 2025
- Completion date
- November 15, 2026
- Enrollment
- 170 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol use disorder, postoperative complications